Supplier profile
ROCHE FARMA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 30 Jun 2008 to 7 Oct 2026.
Awards won
1,072
all time
Attributed value
€1.4bn
217 shared, unvalued
Buyers
292
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 66 | €21.3m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 51 | €27.5m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 41 | €16.4m |
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 40 | €13.4m |
| Dirección General de Planificación Económica | 27 | €36.1m |
| Osakidetza | 26 | €79.6m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 21 | €4.1m |
| Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote | 20 | €6.5m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 20 | €17.7m |
| Hospital Clínico San Carlos de Madrid | 19 | €16.1m |
What they win
Awards
Showing 651–675 of 1,072 awards we hold
- Tocilizumba 20mg/ml vial 4ml. Emergencias Covid-19 ↗Gerencia de los servicios Sanitarios del Area de Salud de La Palma€992awarded 27 Mar 2020
- Spain-Huelva: Pharmaceutical products ↗Servicio Andaluz de Salud, Hospital Universitario Juan Ramón Jiménez de Huelvashared awardawarded 26 Mar 2020
- Spain-Móstoles: Antineoplastic and immunomodulating agents ↗Consejería de Sanidad de la Comunidad de Madrid, Servicio Madrileño de Salud, Hospital Universitario de Móstolesshared awardawarded 25 Mar 2020
- Tocilizumab 20mg/ml vial 10ml, Emergencias Covid-19 ↗Gerencia de los servicios Sanitarios del Area de Salud de La Palma€1kawarded 24 Mar 2020
- Tociluzumab. 20mg/ml vial. 10ml ↗Gerencia de los servicios Sanitarios del Area de Salud de La Palma€7kawarded 23 Mar 2020
- Tociluzumab. 20 mg/ml vial 10ml., Emergencias Covid-19 ↗Gerencia de los servicios Sanitarios del Area de Salud de La Palma€3kawarded 16 Mar 2020
- Spain-Madrid: Pharmaceutical products ↗Hospital Clínico San Carlos de Madrid€449kawarded 9 Mar 2020
- Spain-Madrid: Pharmaceutical products ↗Hospital Clínico San Carlos de Madrid€512kawarded 6 Mar 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de Salud – Hospital Universitario 12 de Octubre€969kawarded 5 Mar 2020
- Spain-Getafe: Various medicinal products ↗Hospital Universitario de Getafe€778kawarded 27 Feb 2020
- Contrato Basado en el Acuerdo Marco para el suministro de medicamentos de uso humano para el tratamiento de fibrosis pulmonar idiopática. ↗Subsecretaría de la Consellería de Sanidad y Salud Pública€5.2mawarded 26 Feb 2020
- Spain-Saragossa: Pharmaceutical products ↗Servicio Aragonés de Salud (Salud)shared awardawarded 21 Feb 2020
- Spain-Granada: Pharmaceutical products ↗Servicio Andaluz de Salud – Hospital Universitario Virgen de las Nievesshared awardawarded 20 Feb 2020
- PNSP 28/2019. Adquisiciòn de los principios activos: Bevaizumab, Atezolizumab, Pertuzumab, Tocilizumab, Pirfenidona y Rituximab (Roche Farma, S.A.)-61034000GU19SUM00027 ↗Gerencia del Area de Atención Integrada de Guadalajara€4.6mawarded 14 Feb 2020
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de Salud, Hospital Universitario 12 de Octubre€117kawarded 11 Feb 2020
- Spain-Murcia: Pharmaceutical products ↗Servicio Murciano de Salud€30.6mawarded 10 Feb 2020
- Spain-Seville: Pharmaceutical products ↗Servicio Andaluz de Salud – Área Hospitalaria Virgen del Rocío€1.7mawarded 3 Feb 2020
- Spain-Alcalá de Henares: Various medicinal products ↗Servicio Madrileño de Salud — Hospital Universitario Príncipe de Asturias€1.7mawarded 31 Jan 2020
- Acuerdo Marco para suministro de medicamentos trastuzumab (herceptin), rituximab (mabthera), pertuzumab (perjeta), pirfenidona (esbriet), trastuzumab.emtansina (kadcycla) ↗Inspección General de Sanidad de la Defensa€1.4mawarded 29 Jan 2020
- Spain-Majadahonda: Pharmaceutical products ↗Hospital Universitario Puerta de Hierro de Majadahonda€2.1mawarded 23 Jan 2020
- Spain-Valencia: Immunosuppressive agents ↗Subsecretaría de la Consellería de Sanidad y Salud Públicashared awardawarded 20 Jan 2020
- Spain-Igualada: Pharmaceutical products ↗Consorci Sanitari de l'Anoiashared awardawarded 16 Jan 2020
- Spain-St. Joan Despí: Various medicinal products ↗Consorci Sanitari Integral€465kawarded 9 Jan 2020
- Suministro de medicamentos de uso humano, cuyo principio activo contiene OCRELIZUMAB, para la Gerencia de los Servicios Sanitarios del Área de Salud de Lanzarote, mediante procedimiento negociado sin publicidad, art. 168 LCSP ↗Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote€224kawarded 8 Jan 2020
- Spain-Santander: Pharmaceutical products ↗Servicio Cántabro de Salud€834kawarded 2 Jan 2020
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.